Rotavirus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-06-04
EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.
Rotarix, a live attenuated human rotavirus vaccine, has been authorised for use in the European Union to prevent rotavirus infections.